Willis C. Lee - Aug 25, 2021 Form 4 Insider Report for Emmaus Life Sciences, Inc. (EMMA)

Role
Vice Chairman & COO, Director
Signature
Willis C. Lee
Stock symbol
EMMA
Transactions as of
Aug 25, 2021
Transactions value $
$7,624
Form type
4
Date filed
8/27/2021, 05:42 PM
Previous filing
May 28, 2021
Next filing
Sep 10, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EMMA Common stock, $0.001 par value Purchase $3.62K +2.4K +0.96% $1.51* 253K Aug 25, 2021 Direct F1
transaction EMMA Common stock, $0.001 par value Purchase $1.69K +1K +0.4% $1.69* 254K Aug 26, 2021 Direct F2
transaction EMMA Common stock, $0.001 par value Purchase $2.31K +1.5K +0.59% $1.54* 256K Aug 27, 2021 Direct F3
holding EMMA Common stock, $0.001 par value 109K Aug 25, 2021 By Fidelity Traditional IRA FBO Willis C. Lee
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.44 to $1.55, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnotes (2) and (3) to this Form 4.
F2 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.55 to $1.80, inclusive.
F3 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.49 to $1.57, inclusive.